Global Spinal Cord Stimulation Market: Industry Analysis & Outlook 2017-2021 – Research and Markets

[junkie-button url=”” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]

Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021) provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Outside the U.S. region. The report profiles the key players of the market including Nevro Corporation, Medtronic Plc., Abbott Laboratories (St. Jude) and Boston Scientific.

The U.S. is the main contributor to the SCS market with increasing chronic back pain prevalence and rising addressable population for SCS. The U.S. has great potential in the years ahead with favorable reimbursement policies and improved health service quality. The growth of SCS outside the U.S. is driven by increasing awareness and need for new therapies and devices. The market is relatively small due to lack of reimbursements, that limits the growth of the market.

The global SCS market is expected to grow in future due to growing ageing population, increase in health care expenditure and rising obese population. Key trends of this market include favorable reimbursement landscape in the U.S., launch of new products, awareness regarding early treatments, increase in trial SCS treatments, increasing demand for minimally invasive surgeries, increase SCS for predominant back pain and rising mergers & acquisitions activities. However, high cost of treatment, tough regulatory problems and dependency on traditional therapies are some of the factors posing challenge for the market growth.

Key Topics Covered:

1. Market Overview

2. Global Spinal Cord Stimulation (SCS) Market

3. Regional Market

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

  • Nevro Corporation
  • Medtronic Plc
  • Boston Scientific
  • Abbott Laboratories (St. Jude Medical)

More details here.